TY - PAT
T1 - Antisense Arzneimittel gegen das humane interzelluläre Adhäsionsmolekül (ICAM-1)
AU - Sczakiel, Georg
AU - Kretschmer-Kazemi Far, Rosel
N1 - Antisense Arzneimittel gegen das humane interzelluläre Adhäsionsmolekül (ICAM-1)
PVA 18069
Prio EP-Anmeldung
PCT - Nachanmeldung
validiert in EP 19 818 121.6, CN 201980089644.3, JP 2021-542136, KR 10-2021-7026805 , US 17/425,081
PY - 2019/1/25
Y1 - 2019/1/25
N2 - The present invention relates to a specific antisense oligonucleotide which inhibits the expression of the adhesion molecule ICAM-1 in human cells. The present invention further relates to a vector containing said oligonucleotide and a host cell containing said vector or oligonucleotide and a pharmaceutical composition containing said oligonucleotide as well as uses thereof, in particular in the treatment of an inflammatory disease or condition in humans.
AB - The present invention relates to a specific antisense oligonucleotide which inhibits the expression of the adhesion molecule ICAM-1 in human cells. The present invention further relates to a vector containing said oligonucleotide and a host cell containing said vector or oligonucleotide and a pharmaceutical composition containing said oligonucleotide as well as uses thereof, in particular in the treatment of an inflammatory disease or condition in humans.
M3 - Patente, Schutzrechte
M1 - EP3914710A1
ER -